Identification of Guaifenesin–Andrographolide as a Novel Combinatorial Drug Therapy for Epilepsy Using Network Virtual Screening and Experimental Validation
Yunyuan Huang(East China University of Science and Technology), Jian Li(Sir Run Run Shaw Hospital), Jiqun Wang(East China University of Science and Technology), Zhaobing Gao(Guangzhou University of Chinese Medicine), Yixiang Xu(East China University of Science and Technology), Ru-Rong Gu(Chinese Academy of Sciences), Pei Wang(Chinese Academy of Sciences), Xiaokang Li(East China University of Science and Technology), Donglei Shi(Hainan University), Haiyan Xu(Chinese Academy of Sciences), Sicong Qiao(East China University of Science and Technology)
Cited by 5
Related Papers
SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target
|Cell Research|2021|198
Cardioprotective mechanism of SGLT2 inhibitor against myocardial infarction is through reduction of autosis
|Protein & Cell|2021|179
Enhanced cytotoxicity to cancer cells by mitochondria-targeting MWCNTs containing platinum(IV) prodrug of cisplatin
|Biomaterials|2013|118
Evaluation of HOCl-generating anticancer agents by an ultrasensitive dual-mode fluorescent probe
|Chemical Science|2019|118